In the tumor microenvironment, TGF-β, Chemokine 4/12 (CXCL4/12), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), etc. can enhance EMT. This evidence concerns the gene TGFB1 and neoplasm.